Share of Clicks for top 10 US Healthcare & Medical Biotech / Medical Equipment brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| cslplasma.com | 5.86 |
| thecpapshop.com | 4.27 |
| cvs.com | 4.23 |
| ascensiadiabetes.com | 3.19 |
| clearchoice.com | 3.12 |
| 23andme.com | 3.01 |
| lofta.com | 2.66 |
| dexcom.com | 2.34 |
| biolifeplasma.com | 2.23 |
| octapharmaplasma.com | 2.03 |
| others | 67.06 |
- cslplasma.com - 5.86%
- thecpapshop.com - 4.27%
- cvs.com - 4.23%
- ascensiadiabetes.com - 3.19%
- clearchoice.com - 3.12%
- 23andme.com - 3.01%
- lofta.com - 2.66%
- dexcom.com - 2.34%
- biolifeplasma.com - 2.23%
- octapharmaplasma.com - 2.03%
- others - 67.06%
Copyright © Adthena. All rights reserved.
In the healthcare PPC landscape, ‘others’ dominate with 67.06% click share, while CSL Plasma leads individual advertisers at 5.86%.
Share of Spend for the top 10 US Healthcare & Medical Biotech / Medical Equipment brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | clearchoice.com | dexcom.com | thecpapshop.com | ascensiadiabetes.com | biolifeplasma.com | cslplasma.com | cvs.com | lofta.com | forbes.com | invisalign.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/03/01 | 7.57% | 2.44% | 3.62% | 1.36% | 2.17% | 2.7% | 2.41% | 2.6% | 1.64% | 2.68% |
| 2026/03/02 | 9.44% | 2.08% | 4.12% | 0.99% | 1.86% | 1.5% | 2.26% | 3.42% | 1.48% | 2.19% |
| 2026/03/03 | 8.02% | 2.07% | 4.59% | 1.64% | 1.77% | 2.37% | 3.56% | 2.86% | 1.47% | 1.38% |
| 2026/03/04 | 7.38% | 1.92% | 4.15% | 1.63% | 1.5% | 2.19% | 3.37% | 3.27% | 1.56% | 1.73% |
| 2026/03/05 | 7.19% | 1.85% | 3.74% | 2.14% | 1.68% | 2.36% | 2.91% | 3.96% | 1.88% | 2.97% |
| 2026/03/06 | 7.89% | 2.33% | 4.19% | 2.9% | 2.49% | 2.28% | 2.83% | 4% | 2.19% | 2.96% |
| 2026/03/07 | 8.14% | 3.13% | 3.25% | 2.67% | 2.61% | 2.78% | 2.31% | 3.96% | 2.78% | 3.2% |
| 2026/03/08 | 7.2% | 2.58% | 2.92% | 3.48% | 2.41% | 2.7% | 2.51% | 3.71% | 1.61% | 3.27% |
| 2026/03/09 | 7.03% | 2.38% | 3.67% | 2.52% | 2.31% | 2.21% | 3.09% | 2.73% | 1.59% | 3.96% |
| 2026/03/10 | 7.44% | 2.4% | 3.45% | 2.37% | 2.26% | 2.55% | 2.68% | 4.15% | 2.01% | 1.53% |
| 2026/03/11 | 6.81% | 2.76% | 2.5% | 2.63% | 3.21% | 3.56% | 1.88% | 3.7% | 1.6% | 1.76% |
| 2026/03/12 | 7.07% | 2.82% | 3.99% | 2.13% | 3% | 2.89% | 2.23% | 3.79% | 1.89% | 1.73% |
| 2026/03/13 | 6.7% | 2.15% | 4.32% | 2.37% | 2.85% | 3.23% | 3.02% | 3.72% | 1.95% | 1.16% |
| 2026/03/14 | 5.71% | 2.32% | 3.96% | 3% | 2.5% | 1.8% | 3.02% | 2.79% | 3.88% | 1.34% |
| 2026/03/15 | 3.91% | 1.88% | 4.12% | 3.93% | 1.89% | 3.14% | 2.74% | 4.08% | 2.55% | 1.48% |
| 2026/03/16 | 4.96% | 2.08% | 3.48% | 3.96% | 2.93% | 2.74% | 3.32% | 2.93% | 2.38% | 0.8% |
| 2026/03/17 | 3.1% | 2.09% | 4.41% | 3.8% | 2.14% | 1.22% | 3.68% | 3.39% | 1.49% | 1.02% |
| 2026/03/18 | 5.76% | 2.52% | 3.74% | 3.78% | 2.89% | 2.81% | 2.76% | 3.05% | 2.11% | 2.02% |
| 2026/03/19 | 6.14% | 2.53% | 4.44% | 3.58% | 2.43% | 2.6% | 2.71% | 2.54% | 1.88% | 1.44% |
| 2026/03/20 | 6.11% | 2.69% | 3.28% | 3.15% | 2.28% | 1.84% | 3.31% | 3.04% | 2.25% | 1.31% |
| 2026/03/21 | 7.56% | 2.85% | 2.82% | 2.57% | 2.48% | 2.55% | 2.59% | 2.71% | 2.6% | 3.06% |
| 2026/03/22 | 7.15% | 2.39% | 3.17% | 3.59% | 1.84% | 2.92% | 1.85% | 1.88% | 2.57% | 1.96% |
| 2026/03/23 | 6.33% | 2.61% | 2.14% | 2.62% | 1.97% | 3.16% | 3.3% | 1.39% | 2.37% | 2.36% |
| 2026/03/24 | 5.01% | 3.4% | 4.41% | 2.94% | 1.55% | 2.1% | 2.69% | 1.35% | 2.44% | 2.4% |
| 2026/03/25 | 5.15% | 1.76% | 3.97% | 3.05% | 2.57% | 1.91% | 2.15% | 2.28% | 2.19% | 5.72% |
| 2026/03/26 | 5.28% | 2.47% | 4.3% | 3.48% | 1.97% | 2.41% | 2.86% | 2.31% | 1.6% | 1.51% |
| 2026/03/27 | 6.47% | 3.28% | 3.95% | 3.24% | 1.83% | 2.71% | 1.73% | 2.91% | 2.03% | 2.29% |
| 2026/03/28 | 7.32% | 2.75% | 4.28% | 3.4% | 2.52% | 2.77% | 1.67% | 1.74% | 2.15% | 0.67% |
| 2026/03/29 | 5.28% | 3.56% | 3.38% | 3.01% | 2.9% | 2.39% | 2.12% | 1.47% | 2.2% | 3.06% |
| 2026/03/30 | 6.12% | 3.44% | 2.96% | 3.08% | 3.84% | 1.93% | 1.95% | 1.22% | 2.42% | 3.85% |
| 2026/03/31 | 5.52% | 3.82% | 3.65% | 3.49% | 3.24% | 2.8% | 2.41% | 2.08% | 1.93% | 1.74% |
- clearchoice.com
- dexcom.com
- thecpapshop.com
- ascensiadiabetes.com
- biolifeplasma.com
- cslplasma.com
- cvs.com
- lofta.com
- forbes.com
- invisalign.com
Copyright © Adthena. All rights reserved.
In March 2026, ClearChoice’s PPC spend share fluctuated, peaking early at 9.44% and ending at 5.52%. Dexcom’s share rose steadily, closing at 3.82%. The CPAP Shop maintained a consistent presence, while Ascensia Diabetes saw a mid-month surge. BioLife Plasma and CSL Plasma experienced varied trends, with BioLife ending at 3.24% and CSL at 2.8%. CVS’s share dipped mid-month but stabilized at 2.41%. Lofta’s share declined, finishing at 2.08%. Forbes and Invisalign showed inconsistent patterns, with Invisalign closing at 1.74%.
Competitor Count for US Healthcare & Medical Biotech / Medical Equipment
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/03/01 | 1252 |
| 2026/03/02 | 1311 |
| 2026/03/03 | 1330 |
| 2026/03/04 | 1377 |
| 2026/03/05 | 1327 |
| 2026/03/06 | 1262 |
| 2026/03/07 | 1187 |
| 2026/03/08 | 1206 |
| 2026/03/09 | 1250 |
| 2026/03/10 | 1223 |
| 2026/03/11 | 1175 |
| 2026/03/12 | 1176 |
| 2026/03/13 | 1182 |
| 2026/03/14 | 1198 |
| 2026/03/15 | 1198 |
| 2026/03/16 | 1267 |
| 2026/03/17 | 1377 |
| 2026/03/18 | 1260 |
| 2026/03/19 | 1285 |
| 2026/03/20 | 1279 |
| 2026/03/21 | 1178 |
| 2026/03/22 | 1244 |
| 2026/03/23 | 1276 |
| 2026/03/24 | 1215 |
| 2026/03/25 | 1198 |
| 2026/03/26 | 1128 |
| 2026/03/27 | 1128 |
| 2026/03/28 | 1109 |
| 2026/03/29 | 1087 |
| 2026/03/30 | 1137 |
| 2026/03/31 | 1100 |
Copyright © Adthena. All rights reserved.
March began with 1,252 advertisers, peaking at 1,377 on the 4th and 17th. A decline followed, ending the month at 1,100.
